{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:52:10Z","timestamp":1792698730300,"version":"4.5.0"},"reference-count":26,"publisher":"Pharmaceutical Society of Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2022,3,1]]},"DOI":"10.1248\/bpb.b21-00662","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T22:11:19Z","timestamp":1646086279000},"page":"245-249","source":"Crossref","is-referenced-by-count":2,"title":["Effects of Disodium Cromoglycate Treatment in the Early Stage of Diabetic Nephropathy: Focus on Collagen Deposition"],"prefix":"10.1248","volume":"45","author":[{"given":"Mateus Jacinto","family":"da Luz","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Institute of Biomedical Sciences, Federal University of Uberl\u00e2ndia, ICBIM-UFU"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Augusto Alves","family":"da Costa","sequence":"additional","affiliation":[{"name":"Department of Physiology, Institute of Biomedical Sciences, Federal University of Uberl\u00e2ndia, ICBIM-UFU"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula Coelho","family":"Balbi","sequence":"additional","affiliation":[{"name":"Department of Physiology, Institute of Biomedical Sciences, Federal University of Uberl\u00e2ndia, ICBIM-UFU"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Borges","family":"Bispo-da-Silva","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Institute of Biomedical Sciences, Federal University of Uberl\u00e2ndia, ICBIM-UFU"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Sinniah A, Yazid S, Flower RJ. The anti-allergic cromones: past, present, and future. <i>Front. Pharmacol.<\/i>, <b>8<\/b>, 827 (2017).","DOI":"10.3389\/fphar.2017.00827"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Lim AK, Tesch GH. Inflammation in diabetic nephropathy. <i>Mediators Inflamm.<\/i>, <b>2012<\/b>, 146154 (2012).","DOI":"10.1155\/2012\/146154"},{"key":"3","unstructured":"3) Oko\u0144 K, Stachura J. Increased mast cell density in renal interstitium is correlated with relative interstitial volume, serum creatinine and urea especially in diabetic nephropathy but also in primary glomerulonephritis. <i>Pol. J. Pathol.<\/i>, <b>58<\/b>, 193\u2013197 (2007)."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Zheng JM, Yao GH, Cheng Z, Wang R, Liu ZH. Pathogenic role of mast cells in the development of diabetic nephropathy: a study of patients at different stages of the disease. <i>Diabetologia<\/i>, <b>55<\/b>, 801\u2013811 (2012).","DOI":"10.1007\/s00125-011-2391-2"},{"key":"5","unstructured":"5) Khurana H, Sharma S, Budhiraja RD. Effect of mast cell stabilizer, ketotifen on streptozotocin induced experimental diabetic nephropathy in rats. <i>Int. J. Pharm. Sci. Res.<\/i>, <b>2<\/b>, 2387\u20132393 (2011)."},{"key":"6","unstructured":"6) Medapati JR, Paparani MR, Budhiraja RD. The novel role of mast cell stabilizer in halting the development of nephropathy in diabetic rats: implication of resident renal mast cells, 22nd Int. Conference on <i>Med. Biol. Pharmaceut. Sci.<\/i>, Singapore, 84\u201389 (2012)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) de Morais RB, do Couto Muniz VP, Nunes Costa E, Filho SRF, Nakamura Hiraki KR, Bispo-da-Silva LB, Coelho Balbi AP. Mast cell population in the development of diabetic nephropathy: effects of renin angiotensin system inhibition. <i>Biomed. Pharmacother.<\/i>, <b>107<\/b>, 1115\u20131118 (2018).","DOI":"10.1016\/j.biopha.2018.08.066"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Yin DD, Luo JH, Zhao ZY, Liao YJ, Li Y. Tranilast prevents renal interstitial fibrosis by blocking mast cell infiltration in a rat model of diabetic kidney disease. <i>Mol. Med. Rep.<\/i>, <b>17<\/b>, 7356\u20137364 (2018).","DOI":"10.3892\/mmr.2018.8776"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Summers SA, Gan PY, Dewage L, Ma FT, Ooi JD, O\u2019Sullivan KM, Nikolic-Paterson DJ, Kitching AR, Holdsworth SR. Mast cell activation and degranulation promotes renal fibrosis in experimental unilateral ureteric obstruction. <i>Kidney Int.<\/i>, <b>82<\/b>, 676\u2013685 (2012).","DOI":"10.1038\/ki.2012.211"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Oliveira-Silva GL, Morais IBM, Fortunato-Silva J, Alvarez MMP, Fran\u00e7a-Silva N, Galo JA, Hiraki KRN, Balbi APC, Bispo-da-Silva LB. Testosterone and mast cell interactions in the development of kidney fibrosis after unilateral ureteral obstruction in rats. <i>Biol. Pharm. Bull.<\/i>, <b>41<\/b>, 1164\u20131169 (2018).","DOI":"10.1248\/bpb.b17-00829"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Strutz F, Zeisberg M. Renal fibroblasts and myofibroblasts in chronic kidney disease. <i>J. Am. Soc. Nephrol.<\/i>, <b>17<\/b>, 2992\u20132998 (2006).","DOI":"10.1681\/ASN.2006050420"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Gailit J, Marchese MJ, Kew RR, Gruber BL. The differentiation and function of myofibroblasts is regulated by mast cell mediators. <i>J. Invest. Dermatol.<\/i>, <b>117<\/b>, 1113\u20131119 (2001).","DOI":"10.1046\/j.1523-1747.2001.15211.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Lenzen S. The mechanisms of alloxan-and streptozotocin-induced diabetes. <i>Diabetologia<\/i>, <b>51<\/b>, 216\u2013226 (2008).","DOI":"10.1007\/s00125-007-0886-7"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Martin S, Kolb-Bachofen V, Kiesel U, Kolb H. Pathogenesis of low dose streptozotocin induced diabetes in mice: requirement for alpha 1-adrenoceptor activation and vasoactive amine release. <i>Diabetologia<\/i>, <b>32<\/b>, 140\u2013142 (1989).","DOI":"10.1007\/BF00505187"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Bradding P, Pejler G. The controversial role of mast cells in fibrosis. <i>Immunol. Rev.<\/i>, <b>282<\/b>, 198\u2013231 (2018).","DOI":"10.1111\/imr.12626"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Young BA, Johnson RJ, Alpers CE, Eng E, Gordon K, Floege J, Couser WG, Seidel K. Cellular events in the evolution of experimental diabetic nephropathy. <i>Kidney Int.<\/i>, <b>47<\/b>, 935\u2013944 (1995).","DOI":"10.1038\/ki.1995.139"},{"key":"17","unstructured":"17) Li H, Zhang Z, Wen HL, Ruan Y. Expression of alpha-smooth muscle actin in kidney of diabetic rats. <i>Zhejiang Da Xue Xue Bao Yi Xue Ban<\/i>, <b>34<\/b>, 152\u2013156 (2005)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Yuan Q, Tan RJ, Liu Y. Myofibroblast in kidney fibrosis: origin, activation, and regulation. <i>Adv. Exp. Med. Biol.<\/i>, <b>1165<\/b>, 253\u2013283 (2019).","DOI":"10.1007\/978-981-13-8871-2_12"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Falke LL, Gholizadeh S, Goldschmeding R, Kok RJ, Nguyen TQ. Diverse origins of the myofibroblast\u2014implications for kidney fibrosis. <i>Nat. Rev. Nephrol.<\/i>, <b>11<\/b>, 233\u2013244 (2015).","DOI":"10.1038\/nrneph.2014.246"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Silva GE, Costa RS, Ravinal RC, dos Reis MA, Dantas M, Coimbra TM. Mast cells, TGF-beta1 and alpha-SMA expression in IgA nephropathy. <i>Dis. Markers<\/i>, <b>24<\/b>, 181\u2013190 (2008).","DOI":"10.1155\/2008\/725408"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Makino H, Kashihara N, Sugiyama H, Kanao K, Sekikawa T, Okamoto K, Maeshima Y, Ota Z, Nagai R. Phenotypic modulation of the mesangium reflected by contractile proteins in diabetes. <i>Diabetes<\/i>, <b>45<\/b>, 488\u2013495 (1996).","DOI":"10.2337\/diabetes.45.4.488"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Kaikini AA, Dhodi D, Muke S, Peshattiwar V, Bagle S, Korde A, Sarnaik J, Kadwad V, Sachdev S, Sathaye S. Standardization of type 1 and type 2 diabetic nephropathy models in rats: assessment and characterization of metabolic features and renal injury. <i>J. Pharm. Bioallied Sci.<\/i>, <b>12<\/b>, 295\u2013307 (2020).","DOI":"10.4103\/jpbs.JPBS_239_19"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Persson P, Fasching A, Teerlink T, Hansell P, Palm F. L-Citrulline, but not L-arginine, prevents diabetes mellitus-induced glomerular hyperfiltration and proteinuria in rat. <i>Hypertension<\/i>, <b>64<\/b>, 323\u2013329 (2014).","DOI":"10.1161\/HYPERTENSIONAHA.114.03519"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Al-Qattan KK, Thomson M, Jayasree D, Ali M. Garlic attenuates plasma and kidney ACE-1 and AngII modulations in early streptozotocin-induced diabetic rats: renal clearance and blood pressure implications. <i>Evid. Based Complement. Alternat. Med.<\/i>, <b>2016<\/b>, 8142394 (2016).","DOI":"10.1155\/2016\/8142394"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Malatiali S, Francis I, Barac-Nieto M. Insulin prevents hyperfiltration and proteinuria but not glomerular hypertrophy and increases mesangial matrix expansion in diabetic rats. <i>Med. Princ. Pract.<\/i>, <b>26<\/b>, 78\u201383 (2017).","DOI":"10.1159\/000450864"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Slaughter TN, Paige A, Spires D, Kojima N, Kyle PB, Garrett MR, Roman RJ, Williams JM. Characterization of the development of renal injury in Type-1 diabetic Dahl salt-sensitive rats. <i>Am. J. Physiol. Regul. Integr. Comp. Physiol.<\/i>, <b>305<\/b>, R727\u2013R734 (2013).","DOI":"10.1152\/ajpregu.00382.2012"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/45\/3\/45_b21-00662\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T04:13:59Z","timestamp":1646453639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/45\/3\/45_b21-00662\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b21-00662","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]},"article-number":"b21-00662"}}